Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions
Authors not listed
Baumann Cosmetic and Research Institute · 2015
Abstract
This study is to determine the efficacy and safety of JUVÉDERM VOLUMA™ XC when used in the facial temporal regions based on the change in the score of the investigator's Temporal. This study will be an open label, single center study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2015). Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions. <em>Baumann Cosmetic and Research Institute</em>. https://clinicaltrials.gov/study/NCT02437903
Vancouver
Anonymous. Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions. Baumann Cosmetic and Research Institute. 2015.
BibTeX
@misc{anon2015OpenLa,
title = {Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions},
author = {Anonymous},
journal = {Baumann Cosmetic and Research Institute},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Palomar Medical Technologies, Inc. 2007
Open access · US-GOV
Safety and Efficacy Evaluation of Fractional Erbium Treatment
Antria 2013
Open access · US-GOV
A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
GeroScience 2024
Preprint · OA
Plasma proteomics-based organ-specific aging for all-cause mortality and cause-specific mortality: a prospective cohort study
SIPO Biotechnology Co. Ltd. 2027
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled Exploratory Clinical Study to Evaluate the Safety and Tolerability of SPOT-mRNA01 Injection in Healthy Adult Subjects.
University of Aarhus 2021
Open access · US-GOV
Bloodflow Restricted Exercise in Healthy Ageing
National Institute on Aging (NIA) 2006
Open access · US-GOV